Back to
LPL Financial LLC
XLO
4 quarters
Position history for
LPL Financial LLC's holdings in Xilio Therapeutics, Inc.
No. LPL Financial exited its XLO (Xilio Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 21,000 shares worth $13,444. LPL Financial first reported XLO in Q2 2025 and held it in 3 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$21,077
Total Shares Change
-31,000
Quarter-by-Quarter History